Without being able to normalize for the associated development costs, we can't really make any justified analysis of what either team should have been able to accomplish.
In the industry we speak to this as "entitlement", project managers and their funding managers know they can't expect blood from a stone. You are only entitled to expect a given return on your R&D investment if you actually made that R&D investment in the first place.
Give the Kabini team 1/10 the resources as you did the Brazos team and you
are not entitled as a business to expect the Kabini team to out-deliver what the Brazos team delivered.
Conversly, give the Kabini team 10x the resources you did the Brazos team and you
are entitled as a business to expect the Kabini team to out-deliver what the Brazos team delivered.
We can make all the comparisons we like between the two products, but in the absence of knowing their associated development costs we cannot reliably make a reasonable analyses of what should have happened, could have happened, ought to have happened, etc.
We don't know what level of entitlement the Kabini team was resourced to deliver to the managing directors. They may have over-delivered despite being under-resources, or they may have under-delivered despite being over-resourced...we will never know unless someone very high up in AMD who would be privy to the big picture numbers decided to make them public and tell us about it.
(Like IBM did with the
45nm CELL shrink)